NASDAQ
No price data available for this timeframe.
The final trades of the day with CNBC's Melissa Lee and the 'Fast Money' traders....
NEW BRUNSWICK, N.J.--(BUSINESS WIRE)--Johnson & Johnson (NYSE: JNJ) will host a conference call for investors at 8:30 a.m. (Eastern Time) on Wednesday, January 21st to review fourth-quarter results. J...
BofA raised Johnson and Johnson's price target to $220, citing steady growth, but sees limited upside from its pipeline through 2026....
Bank of America upgrades Bristol Myers to Buy, lifting its price target to $61 on pipeline catalysts, valuation support, and improving risk-reward outlook....
JNJ secures FDA approval to expand Akeega into earlier-stage prostate cancer, backed by strong phase III data and a first-of-its-kind precision combo....
The U.S. Food and Drug Administration said on Monday it has granted a national priority voucher to Johnson & Johnson's treatment for a type of blood cancer, bringing the total number of products recei...
Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employe...
Liquidia shares have surged 43.9% since an October upgrade, as Zacks highlights stock wins and portfolio results despite a volatile market....
Hilltop Partners LLC increased its holdings in shares of Johnson and Johnson (NYSE: JNJ) by 24.7% during the second quarter, according to its most recent Form 13F filing with the Securities and Exchan...
Geneos Wealth Management Inc. cut its position in shares of Johnson and Johnson (NYSE: JNJ) by 12.4% in the undefined quarter, according to its most recent disclosure with the Securities and Exchange ...